By Daniel Yee
Since the early 1990s, a class of antibiotic drugs known as fluoroquinolones has provided a relatively easy cure for gonorrhea, but a growing number of gonorrhea cases is resistant to those drugs, and officials at the CDC for the first time are urging doctors to stop using fluoroquinolones for gonorrhea and switch to cephalosporins.
The sexually transmitted disease gonorrhea is now among the "superbugs" resistant to common antibiotics, leading U.S. health officials to recommend wider use of a different class of drugs to avert a public health crisis.
The resistant form accounts for more than one in every four gonorrhea cases among heterosexual men in Philadelphia and nearly that many in San Francisco, according to a survey that led to Thursday's recommendation by the Centers for Disease Control and Prevention.
Gonorrhea, which is believed to infect more than 700,000 people in the United States each year, can leave both men and women infertile and puts people at higher risk of getting the AIDS virus.
Since the early 1990s, a class of drugs known as fluoroquinolones has provided a relatively easy cure. These antibiotics, taken as tablets, include the drug Cipro.
Penicillin used to be able to handle the brunt of all diseases, but the infirmities have become tougher. It’s now an escalating arms race against the germs. STDs are the poster children for the phrase “an ounce of cure is worth a pound of prevention.” We may have gotten that backwards, but you get the point. The scared-straight effect of Magic Johnson’s AIDS confessional seemed to have worn off. These stupid diseases are making it tougher for swingin’ singles to have consequence-free, unprotected intercourse. Let’s hope that a new wave of STDs does not inspire us to go back to our baggy jeans and flannel shirt cocoons.